Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Interfering virus" patented technology

A virus which prevents replication of another virus; may be due to blocking of virus attachment sites or the presence of defective interfering particles which block the replication of competent ones.

Apparatus for producing canine feline interferon complex peptide

ActiveCN224293539UCentrifugesCellular DebrisInterfering virus
The utility model relates to the technical field of preparation device, specifically disclose a kind of preparation device of canine feline interference virus compound peptide, including base, motor is fixedly installed in base middle part, motor output shaft end portion is fixedly installed with disc, disc side edge is equipped with the evenly distributed limit mouth, disc is located in the limit mouth side edge and is all equipped with through -going hole, disc side edge, limit mouth and through -going hole are all set to be inclined, through -going hole is equipped with centrifugal tube, centrifugal tube is set to be through -going, the plug of centrifugal tube top is fixedly connected, the size of plug is compatible with the size of limit mouth, the preparation device of canine feline interference virus compound peptide, can quickly directly canine feline cell liquid solid-liquid separation, using centrifugal force quickly makes cell debris, solid impurities such as organelle sedimentation and isolation, efficiently obtain the clear solution containing target interference virus compound peptide, strong practicality.
Owner:HARBIN TAIYUAN BIOTECHNOLOGY CO LTD

New application of fructus arctii essential oil and ganoderma lucidum spore oil, pharmaceutical composition for treating human papilloma virus infection as well as preparation method and application of pharmaceutical composition

PendingCN121041335AAntiviralsPlant ingredientsFormularyHuman papilloma virus infection
The invention provides application of fructus arctii essential oil in preparation of an external medicine for resisting human papilloma virus. The invention further provides application of the ganoderma lucidum spore oil in preparation of the external medicine for resisting the human papilloma virus. The invention provides a pharmaceutical composition for treating human papilloma virus infection. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 3.2-4.8 parts of fructus arctii essential oil and 0.8-1.2 parts of ganoderma lucidum spore oil. The invention also provides a preparation method and application of the pharmaceutical composition. According to the invention, a compounding process is adopted, the formula of main medicines and auxiliary materials is determined, the compound ganoderma lucidum essential oil with good stability is successfully prepared, and a thin-layer chromatography method and a gas chromatography quality evaluation method for the main medicines in the compound are preliminarily established. The compound coriolus versicolor essential oil is administrated in a local smearing mode, in-vitro experiments show that the compound coriolus versicolor essential oil can interfere with virus replication and is high in antiviral effect, especially for HPV16, the effect is mild, no stimulation to skin is found through clinical observation, and adverse reactions are few.
Owner:FUJIAN PROVINCIAL HOSPITAL

Antiviral compounds, compositions and methods of use

ActiveUS12622896B2Organic active ingredientsOrganic chemistryInterfering virusCytoplasm
Provided herein are antiviral compounds having the structure of Formula (I) and compositions thereof for use in the treatment of viral infection. In particular, the compounds of Formula (I) are capable of interfering with the export of viral mRNA processing as reflected in the altered accumulation of viral RNA isoforms as well as transport from the nucleus to the cytoplasm. Such compounds show a reduction of HIV, adenovirus and coronavirus infection of cells. The invention provides compounds that may be suitable for the treatment of HIV / AIDS.
Owner:SOCIETE DE COMMERCIALISATION DES PRODUITS DE LA RECHERCHE APPLIQUEE SOCPRA ET HUMAINES S E C +2